|
|
||||||||
From the Department of Neurology (Drs. Tan, Matsuura, Nagamitsu, Jankovic, and Ashizawa, and M. Khajavi), Baylor College of Medicine; and the Neurology Service (Drs. Matsuura, Nagamitsu, and Ashizawa, and M. Khajavi), VA Medical Center, Houston, TX.
Address correspondence and reprint requests to Dr. Tetsuo Ashizawa, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Smith 1801, Houston, TX 77030; e-mail: tetsuoa{at}bcm.tmc.edu
An allele (263bp) of the nonamyloid component of plaques (NACP)-Rep1 polymorphism has shown association with sporadic PD in a German population. The authors studied this polymorphism in 100 American PD patients and 100 healthy controls. The authors also studied 46 essential tremor (ET) and 55 Huntingtons disease (HD) patients. Allele 263bp was significantly higher in PD patients (OR = 3.86) and ET patients (OR = 6.42) but not HD patients, compared with healthy controls. The association of allele 263bp with PD and ET suggests a possible etiologic link between these two conditions.
Key words: PDEssential tremorNACPRep1Polymorphism.
This article has been cited by other articles:
![]() |
E. D. Louis, J. Benito-Leon, F. Bermejo-Pareja, and On behalf of the Neurological Disorders in Central Population-based prospective study of cigarette smoking and risk of incident essential tremor Neurology, May 6, 2008; 70(19): 1682 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Deng, W. Le, and J. Jankovic Genetics of essential tremor Brain, June 1, 2007; 130(6): 1456 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Maraganore, M. de Andrade, A. Elbaz, M. J. Farrer, J. P. Ioannidis, R. Kruger, W. A. Rocca, N. K. Schneider, T. G. Lesnick, S. J. Lincoln, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA, August 9, 2006; 296(6): 661 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Tan, A. Chai, Y. Y. Teo, Y. Zhao, C. Tan, H. Shen, V. R. Chandran, M. L. Teoh, Y. Yih, R. Pavanni, et al. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease Neurology, January 13, 2004; 62(1): 128 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Nussbaum and C. E. Ellis Alzheimer's Disease and Parkinson's Disease N. Engl. J. Med., April 3, 2003; 348(14): 1356 - 1364. [Full Text] [PDF] |
||||
![]() |
O. CHIBA-FALEK and R.L. NUSSBAUM Regulation of {alpha}-Synuclein Expression: Implications for Parkinson's Disease Cold Spring Harb Symp Quant Biol, January 1, 2003; 68(0): 409 - 416. [Abstract] [PDF] |
||||
![]() |
T Foltynie, S Sawcer, C Brayne, and R A Barker The genetic basis of Parkinson's disease J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 363 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Chiba-Falek and R. L. Nussbaum Effect of allelic variation at the NACP-Rep1 repeat upstream of the {alpha}-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system Hum. Mol. Genet., December 1, 2001; 10(26): 3101 - 3109. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Spillantini and M. Goedert Tau and Parkinson Disease JAMA, November 14, 2001; 286(18): 2324 - 2326. [Full Text] [PDF] |
||||
![]() |
M. Farrer, D. M. Maraganore, P. Lockhart, A. Singleton, T.G. Lesnick, M. de Andrade, A. West, R. de Silva, J. Hardy, and D. Hernandez {alpha}-synuclein gene haplotypes are associated with Parkinson's disease Hum. Mol. Genet., August 1, 2001; 10(17): 1847 - 1851. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |